Yoon et al. compared the positivity of these three immunomarkers and found that the positivity of TRPS1 was 99% for triple-negative ductal carcinoma vs. 63% and 74% for GATA3 and SOX10, respectively [9]. The gene discussed is TRPS1; the disease is breast ductal adenocarcinoma.